Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Embla Medical hfOSSFF 91 Equity-to-Asset is 0.53 as of Mar. 2026, which is 6% above its 10-year median of 0.50. GuruFocus rates OSSFF with a GF Score™ of 91/100 and a GF Value™ of $5.43. The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Embla Medical hf ranks worse than 63.82% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Embla Medical hf's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $899.3 Mil. Embla Medical hf's Total Assets for the quarter that ended in Mar. 2026 was $1,709.1 Mil.
Therefore, Embla Medical hf's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.53.
The historical rank and industry rank for Embla Medical hf's Equity-to-Asset or its related term are showing as below:
OSSFF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.45 Med: 0.5 Max: 0.63
Current: 0.53
During the past 13 years, the highest Equity to Asset Ratio of Embla Medical hf was 0.63. The lowest was 0.45. And the median was 0.50.
OSSFF's Equity-to-Asset is ranked worse than 63.82% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs OSSFF: 0.53
Embla Medical hf (OTCPK:OSSFF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Embla Medical hf Equity-to-Asset Related Terms
Embla Medical hf Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSSFF vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Embla Medical hf's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Embla Medical hf's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf (OSSFF) has a Equity-to-Asset of 0.53 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Embla Medical hf and its competitors. This is near median its historical median of 0.50. Over the past decade, Embla Medical hf's Equity-to-Asset has ranged from 0.45 to 0.63. According to the industry distribution chart, Embla Medical hf ranks #545 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 63.8%.
Is Embla Medical hf's Equity-to-Asset too high?
Embla Medical hf's current Equity-to-Asset of 0.53 is near median its 10-year median of 0.50. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 0.63. The Medical Devices & Instruments industry median Equity-to-Asset is 0.65. Embla Medical hf's value of 0.53 is 18.5% below this industry median. Based on the distribution chart, Embla Medical hf ranks #545 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #545 out of 854 companies for Equity-to-Asset. This places Embla Medical hf in the lower half of its industry. The industry median Equity-to-Asset is 0.65. Embla Medical hf's value of 0.53 is 18.5% below this benchmark. Historically, Embla Medical hf's own Equity-to-Asset has ranged from 0.45 to 0.63 over the past decade. While the company's 10-year median is 0.50 vs. the industry median of 0.65, Embla Medical hf has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.65, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current Equity-to-Asset of 0.53 is 18.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Equity-to-Asset is 0.53, which is near median its own 10-year median of 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Equity-to-Asset of 0.53. The stock's GF Value™ is $5.43, compared to a current price of $4.15 — trading 23.6% below its estimated fair value. The current Equity-to-Asset is 0.53, which is near median its 10-year median of 0.50 and 18.5% below the Medical Devices & Instruments industry median of 0.65. Embla Medical hf's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Equity-to-Asset is 0.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 23.6% below its estimated GF Value™ of $5.43.
Key valuation signals for OSSFF:
Equity-to-Asset: 0.53 (near median its 10-year median of 0.50)
GF Value™: $5.43 vs. price of $4.15 (23.6% below fair value)
Industry Position: 18.5% below the Medical Devices & Instruments median (#545 of 854)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
91GF Score
Get the complete analysis for OSSFF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
